Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Washington guideWashington Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Washington
  4. ›Healthcare and Medical Services
  5. ›Culturally Specific Treatment of Opioid Use Disorder NOFA

City of Spokane·Washington

Culturally Specific Treatment of Opioid Use Disorder NOFA

Closes 12/15/2025$200k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The City of Spokane is offering a grant to develop and deliver culturally specific treatment services for Opioid Use Disorder (OUD) targeting historically marginalized populations. Applicants must demonstrate capacity to design, launch, and evaluate such programs, provide detailed budgeting, and meet extensive insurance and compliance requirements. The grant is funded from opioid litigation settlements and can award up to $500,000, with a portion of seed funding available upfront. The contract period runs through December 31 2026, with a possible one‑year extension. • Provide culturally tailored, evidence‑based OUD treatment and prevention services for underserved groups (BIPOC, LGBTQIA+, tribal, disabled, etc.). • Submit a comprehensive proposal by Dec 15 2025, including a cost narrative, KPI reporting plan, and required insurance certificates. • Must retain records for ≥6 years, comply with audit requirements, and maintain specified insurance limits throughout the contract.

Attached files

Contact

Maggie Yates(Procurement Officer)

[email protected]

(509) 625-6753

Key dates

Opened
11/19/2025
Questions due
12/5/2025
Pre-bid meeting
12/3/2025
Closes
12/15/2025
Projected award
4/29/2026
Duration
1 year

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
624120
Solicitation №
GRANT 6468-25

Budget estimate

$200,000 – $500,000

The grant advertises a maximum award of $500,000, with seed funding up to $50,000 and the remainder reimbursed after expenses. Assuming most applicants request near‑full funding, the realistic budget range is roughly $200,000 to $500,000, depending on program scope, staffing, and cost structure.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

Arkansas Department of Finance and Administration·Arkansas

Top match · 66%

Comprehensive Opioid Abuse Program (COAP) Comprehensive Opioid Abuse Request for Application (RFA)-Category 4: Regional Efforts Special Project Tracking your COAP/COSSAP Data COAP 2/COAP 4 Subrecipient Workshops and Resources Comprehensive Opioid Abuse Request For Application (RFA) – Category 2 Comprehensive Opioid Abuse Request For Application (RFA) – Category 4 COAP CATEGORY 4-Special Project – Notice of Availability of Funds

Rolling / TBD closeOpened 12/5/2025

U.S. National Institutes of Health·United States of America

66% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. Office of Juvenile Justice Delinquency Prevention·United States of America

66% match

OJJDP FY 2026 Opioid Affected Youth Initiative

Closes 11/16/2026Opened 10/9/2026

U.S. National Institutes of Health·United States of America

65% match

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 9/11/2023

U.S. National Institutes of Health·United States of America

65% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

Arkansas Department of Finance and Administration·Arkansas

65% match

Comprehensive Opioid Abuse Request for Application (RFA)-Category 4: Regional Efforts Special Project

Rolling / TBD closeOpened 12/5/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

65% match

Improving Linkage to Care for People with Opioid Use Disorder (U01)

Closes 12/30/2026Opened 7/2/2026

U.S. Bureau of Justice Assistance·United States of America

64% match

BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)

Closes 11/2/2026Opened 9/21/2026

U.S. Substance Abuse and Mental Health Services Adminis·United States of America

64% match

Emergency Department Alternatives to Opioids Program

Rolling / TBD closeOpened 9/3/2026

U.S. National Institutes of Health·United States of America

64% match

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Closes 11/17/2026Opened 11/22/2023

Florida Department of Children and Families (DCF)·Florida

63% match

Integrated Mobile Community and Jail Medication Assisted Treatment (MAT)

Closes 11/27/2026Opened 7/13/2026

U.S. National Institutes of Health·United States of America

63% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. Substance Abuse and Mental Health Services Adminis·United States of America

63% match

First Responders-Comprehensive Addiction and Recovery Act

Rolling / TBD closeOpened 10/30/2026

U.S. National Institutes of Health·United States of America

63% match

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

Closes 1/7/2027Opened 11/22/2023

U.S. National Institutes of Health·United States of America

63% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. Health Resources and Services Administration·United States of America

62% match

Rural Communities Opioid Response Program - Overdose Response

Closes 4/8/2027Opened 8/21/2026

U.S. National Institutes of Health·United States of America

62% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

County of Ocean·New Jersey

62% match

Innovative Substance Use Programming

Closes 11/5/2026Opened 10/7/2026

U.S. Office of Juvenile Justice Delinquency Prevention·United States of America

62% match

OJJDP FY 2026 Family Treatment Court Program

Closes 11/16/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

62% match

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

Closes 9/24/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

61% match

HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)

Closes 1/26/2027Opened 7/17/2025

U.S. National Institutes of Health·United States of America

61% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

61% match

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)

Closes 5/7/2027Opened 10/12/2023

U.S. National Institutes of Health·United States of America

61% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

61% match

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Closes 5/7/2027Opened 8/16/2023